refractory pancreatic cancer
Showing 26 - 50 of >10,000
Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib
Completed
- Advanced Malignant Solid Neoplasm
- +6 more
- Afatinib Dimaleate
- +2 more
-
Indianapolis, Indiana
- +1 more
Jun 3, 2022
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023
Advanced Pancreatic Cancer Trial in Baltimore (galeterone, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 10, 2022
Pancreatic Ductal Adenocarcinoma, Sarcoma Trial in Iowa City (Decitabine, Gemcitabine)
Active, not recruiting
- Pancreatic Ductal Adenocarcinoma
- Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Dec 3, 2021
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,
Recruiting
- Neuroendocrine Tumors
- +4 more
- [212Pb] VMT-α-NET
- [203Pb] VMT-α-NET SPECT/CT
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),
Recruiting
- Solid Tumor, Adult
- +19 more
- SNS-101 (anti-VISTA)
- Cemiplimab
-
Irving, Texas
- +2 more
May 24, 2023
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
-
Tampa, Florida
- +7 more
Jul 13, 2022
Tumor, Solid, Gall Bladder Cancer, Cervical Cancer Trial in Santiago, Vina del Mar (Andes-1537 for Injection)
Completed
- Tumor, Solid
- +5 more
- Andes-1537 for Injection
-
Santiago, Region Metropolitana, Chile
- +3 more
Feb 23, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Pancreas Cancer Trial in Jinan (Sintilimab Plus mFFN and Radiation)
Recruiting
- Pancreas Cancer
- Sintilimab Plus mFFN and Radiation
-
Jinan, Shandong, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and I
Sep 21, 2023
Solid Tumor, Soft Tissue Sarcoma, Gastric Cancer Trial in Shanghai (CCT301-59)
Active, not recruiting
- Solid Tumor
- +4 more
- CCT301-59
-
Shanghai, Shanghai, ChinaShanghai Zhongshan Hospital
Oct 19, 2021
Pancreatic Tumors Trial in Worldwide (hMN14 (labetuzumab))
Completed
- Pancreatic Neoplasms
- hMN14 (labetuzumab)
-
Newport Beach, California
- +9 more
Aug 12, 2021
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Taiwan, United States (AbGn-107)
Terminated
- Gastric Cancer
- +3 more
- AbGn-107
-
Phoenix, Arizona
- +8 more
Jul 8, 2021
Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,
Active, not recruiting
- Solid Tumor
- +4 more
- LY3300054
- +4 more
-
Nashville, Tennessee
- +14 more
Jul 21, 2022
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Pancreatic Cancer, Cachexia, Chemo Effect Trial in Taipei (MS-20, Placebo)
Recruiting
- Pancreatic Cancer
- +2 more
- MS-20
- Placebo
-
Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hosp
Jan 17, 2023
Candidates for Neoadjuvant Treatment in Resectable Pancreatic
Completed
- Pancreatic Cancer
- Neoadjuvant
- Neoadjuvant treatment
- (no location specified)
Nov 9, 2023